ATE281165T1 - Verwendung von pramipexol zur behandlung von restless-legs-syndrom - Google Patents

Verwendung von pramipexol zur behandlung von restless-legs-syndrom

Info

Publication number: ATE281165T1
Authority: AT; Austria
Prior art keywords: pramipexole; restless legs; legs syndrome; treat restless; treat
Prior art date: 1997-01-17

Application number

AT98903378T

Other languages

English (en)

Inventor

Wolfgang H Oertel

Dieter Meier

Baltazar Gomez-Mancilla

J H Montplaisir

Gouin Quest Boulevard

Original Assignee

Upjohn Co

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-17

Filing date

1998-01-16

Publication date

2004-11-15

1998-01-16 Application filed by Upjohn Co, Boehringer Ingelheim Pharma filed Critical Upjohn Co

2004-11-15 Application granted granted Critical

2004-11-15 Publication of ATE281165T1 publication Critical patent/ATE281165T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Anesthesiology (AREA)
Physical Education & Sports Medicine (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicinal Preparation (AREA)
Semiconductor Memories (AREA)
Liquid Crystal Substances (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicines Containing Plant Substances (AREA)
Corsets Or Brassieres (AREA)

AT98903378T 1997-01-17 1998-01-16 Verwendung von pramipexol zur behandlung von restless-legs-syndrom ATE281165T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19701619A DE19701619B4 (de)	1997-01-17	1997-01-17	Verwendung von Pramipexol zur Behandlung des restless legs syndroms
PCT/US1998/000216 WO1998031362A1 (en)	1997-01-17	1998-01-16	Use of pramipexole in the treatment of restless legs syndrome

Publications (1)

Publication Number	Publication Date
ATE281165T1 true ATE281165T1 (de)	2004-11-15

Family

ID=7817708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98903378T ATE281165T1 (de)	1997-01-17	1998-01-16	Verwendung von pramipexol zur behandlung von restless-legs-syndrom

Country Status (24)

Country	Link
EP (1)	EP0989850B1 (de)
JP (2)	JP4406685B2 (de)
KR (2)	KR20000070234A (de)
CN (1)	CN1117564C (de)
AT (1)	ATE281165T1 (de)
AU (1)	AU723119B2 (de)
BG (1)	BG64614B1 (de)
CA (1)	CA2275379C (de)
CZ (1)	CZ289863B6 (de)
DE (2)	DE19701619B4 (de)
ES (1)	ES2231959T3 (de)
FI (1)	FI120135B (de)
HK (1)	HK1024408A1 (de)
HU (1)	HU226564B1 (de)
NO (1)	NO321151B1 (de)
NZ (2)	NZ510007A (de)
PL (1)	PL190898B1 (de)
PT (1)	PT989850E (de)
RO (1)	RO120757B1 (de)
RU (1)	RU2192252C2 (de)
SI (1)	SI20060A (de)
SK (1)	SK284264B6 (de)
WO (1)	WO1998031362A1 (de)
ZA (1)	ZA98420B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6001861A (en) *	1998-01-16	1999-12-14	Pharmacia & Upjohn Company	Use of pramipexole in the treatment of restless legs syndrome
DE19701619B4 (de) *	1997-01-17	2007-10-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Pramipexol zur Behandlung des restless legs syndroms
SE9803760D0 (sv) *	1998-11-04	1998-11-04	Jan Hedner	Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
DE19938825A1 (de) *	1999-08-19	2001-04-26	Boehringer Ingelheim Pharma	Wirkstoffkombination mit Clonidin
DE10220230A1 (de) *	2002-05-06	2003-11-27	Sanol Arznei Schwarz Gmbh	Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
JP2009511618A (ja) *	2005-10-18	2009-03-19	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	中度から重度のむずむず脚症候群（ｒｌｓ）を治療するためのプラミペキソールの使用
CN101442997B (zh) *	2006-04-03	2012-11-14	泰华制药工业有限公司	雷沙吉兰用于治疗多动腿综合征
TR200906997A1 (tr)	2009-09-11	2011-03-21	Sanovel �La� San. Ve T�C. A. �.	Pramipeksol farmasötik bileşimleri.
TR200907554A1 (tr)	2009-10-06	2011-04-21	Sanovel İlaç San.Ve Ti̇c.A.Ş.	Oral yolla dağılan pramıpexole bileşimleri.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0186087B1 (de) *	1984-12-22	1989-08-23	Dr. Karl Thomae GmbH	Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE3843227A1 (de) *	1988-12-22	1990-07-05	Boehringer Ingelheim Kg	Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3933738A1 (de) *	1989-10-10	1991-04-11	Boehringer Ingelheim Kg	Neue verwendung von 2-aminothiazol-derivaten (tsh)
DE3937271A1 (de) *	1989-11-09	1991-05-16	Boehringer Ingelheim Kg	Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4125446A1 (de) *	1991-08-01	1993-02-04	Uwe Dipl Ing Behmann	Verfahren und einrichtung zur elektrischen kurzschlusspruefung und -ortung fuer leitungen, insbesondere fuer fahrleitungen elektrischer bahnen
US5598352A (en) *	1994-09-30	1997-01-28	Cirrus Logic, Inc.	Method and apparatus for audio and video synchronizing in MPEG playback systems
US5650420A (en) *	1994-12-15	1997-07-22	Pharmacia & Upjohn Company	Pramipexole as a neuroprotective agent
DE19701619B4 (de) *	1997-01-17	2007-10-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Pramipexol zur Behandlung des restless legs syndroms

1997
- 1997-01-17 DE DE19701619A patent/DE19701619B4/de not_active Expired - Lifetime
1998
- 1998-01-16 SI SI9820013A patent/SI20060A/sl active Search and Examination
- 1998-01-16 PT PT98903378T patent/PT989850E/pt unknown
- 1998-01-16 DE DE69827387T patent/DE69827387T2/de not_active Expired - Lifetime
- 1998-01-16 PL PL334498A patent/PL190898B1/pl unknown
- 1998-01-16 AU AU60168/98A patent/AU723119B2/en not_active Expired
- 1998-01-16 KR KR1019997006461A patent/KR20000070234A/ko not_active Application Discontinuation
- 1998-01-16 CA CA002275379A patent/CA2275379C/en not_active Expired - Lifetime
- 1998-01-16 WO PCT/US1998/000216 patent/WO1998031362A1/en not_active Application Discontinuation
- 1998-01-16 RU RU99118211/14A patent/RU2192252C2/ru active
- 1998-01-16 KR KR1020057012562A patent/KR100761774B1/ko not_active IP Right Cessation
- 1998-01-16 NZ NZ510007A patent/NZ510007A/en not_active IP Right Cessation
- 1998-01-16 RO RO99-00818A patent/RO120757B1/ro unknown
- 1998-01-16 EP EP98903378A patent/EP0989850B1/de not_active Expired - Lifetime
- 1998-01-16 CZ CZ19992478A patent/CZ289863B6/cs not_active IP Right Cessation
- 1998-01-16 HU HU0001913A patent/HU226564B1/hu unknown
- 1998-01-16 SK SK920-99A patent/SK284264B6/sk not_active IP Right Cessation
- 1998-01-16 CN CN98801721A patent/CN1117564C/zh not_active Expired - Lifetime
- 1998-01-16 AT AT98903378T patent/ATE281165T1/de active
- 1998-01-16 JP JP53336998A patent/JP4406685B2/ja not_active Expired - Lifetime
- 1998-01-16 ES ES98903378T patent/ES2231959T3/es not_active Expired - Lifetime
- 1998-01-16 NZ NZ336804A patent/NZ336804A/xx not_active IP Right Cessation
- 1998-01-19 ZA ZA9800420A patent/ZA98420B/xx unknown
1999
- 1999-07-01 BG BG103543A patent/BG64614B1/bg active Active
- 1999-07-07 NO NO19993360A patent/NO321151B1/no not_active IP Right Cessation
- 1999-07-16 FI FI991616A patent/FI120135B/fi not_active IP Right Cessation
2000
- 2000-06-21 HK HK00103742A patent/HK1024408A1/xx not_active IP Right Cessation
2008
- 2008-10-22 JP JP2008272286A patent/JP2009062388A/ja active Pending

Also Published As

Publication number	Publication date
WO1998031362A1 (en)	1998-07-23
NO993360D0 (no)	1999-07-07
RO120757B1 (ro)	2006-07-28
KR100761774B1 (ko)	2007-10-04
EP0989850B1 (de)	2004-11-03
JP4406685B2 (ja)	2010-02-03
PL190898B1 (pl)	2006-02-28
SI20060A (sl)	2000-04-30
FI120135B (fi)	2009-07-15
HU226564B1 (en)	2009-04-28
DE19701619A1 (de)	1998-07-23
NZ510007A (en)	2004-11-26
FI991616A (fi)	1999-07-16
JP2001511158A (ja)	2001-08-07
AU6016898A (en)	1998-08-07
KR20050085947A (ko)	2005-08-29
NZ336804A (en)	2001-03-30
CN1117564C (zh)	2003-08-13
HUP0001913A2 (hu)	2000-11-28
CZ247899A3 (cs)	2000-01-12
BG64614B1 (bg)	2005-09-30
RU2192252C2 (ru)	2002-11-10
HK1024408A1 (en)	2000-10-13
DE69827387T2 (de)	2005-10-27
DE69827387D1 (de)	2004-12-09
PL334498A1 (en)	2000-02-28
DE19701619B4 (de)	2007-10-11
CN1243439A (zh)	2000-02-02
ZA98420B (en)	1999-07-19
BG103543A (en)	2000-04-28
ES2231959T3 (es)	2005-05-16
JP2009062388A (ja)	2009-03-26
CA2275379C (en)	2006-11-28
AU723119B2 (en)	2000-08-17
NO993360L (no)	1999-07-07
SK92099A3 (en)	2000-08-14
NO321151B1 (no)	2006-03-27
CA2275379A1 (en)	1998-07-23
EP0989850A1 (de)	2000-04-05
HUP0001913A3 (en)	2002-09-30
CZ289863B6 (cs)	2002-04-17
SK284264B6 (sk)	2004-12-01
PT989850E (pt)	2004-12-31
KR20000070234A (ko)	2000-11-25

Publication	Publication Date	Title
ATE313326T1 (de)	2006-01-15	VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
ATE279181T1 (de)	2004-10-15	Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE225176T1 (de)	2002-10-15	Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
ATE262895T1 (de)	2004-04-15	Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
DE69831406D1 (de)	2005-10-06	Verwendung von thiazolidinedion-derivaten zur behandlung des polyzystischen ovarien syndroms und des schwangerschaftsdiabetes
DE60142590D1 (de)	2010-08-26	Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen
ATE241358T1 (de)	2003-06-15	Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69212620D1 (de)	1996-09-12	Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
ATE275400T1 (de)	2004-09-15	Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie vom weiblichen typ
ATE374619T1 (de)	2007-10-15	Verwendung von neurofilamentproteinen zur behandlung von tumoren
ATE281165T1 (de)	2004-11-15	Verwendung von pramipexol zur behandlung von restless-legs-syndrom
DE69829202D1 (de)	2005-04-07	Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
DE60218153D1 (de)	2007-03-29	Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
DE69931487D1 (de)	2006-06-29	Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69924488D1 (de)	2005-05-04	Verwendung von optisch reinem (-) norcisapride in der behandlung des reizdarmsyndroms
ATE361071T1 (de)	2007-05-15	Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DE60128009D1 (de)	2007-05-31	Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE287713T1 (de)	2005-02-15	Verwendung von riluzol zur behandlung multipler sklerose
DE60213365D1 (de)	2006-09-07	Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen
ES2082212T3 (es)	1996-03-16	Nuevos inhibidores de alfa-glucosidasa.
ATE238795T1 (de)	2003-05-15	Verwendung von aminothiazolen zur wund- und hautbehandlung
ATE302009T1 (de)	2005-09-15	Ubichinon qn zur behandlung von migräneschmerzen
DE50003481D1 (de)	2003-10-02	Verwendung von schmutzablösenden formulierungen zur behandlung von oberflächen
DE69926996D1 (de)	2005-10-06	Verwendung von riluzol zur behandlung der retinalischemie
DE10193322D2 (de)	2003-08-21	Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates

Legal Events

Date	Code	Title	Description
2005-08-15	UEP	Publication of translation of european patent specification	Ref document number: 0989850 Country of ref document: EP

Date

Code

Title

Description

2005-08-15

UEP

Publication of translation of european patent specification

Ref document number: 0989850

Country of ref document: EP